全文获取类型
收费全文 | 4472篇 |
免费 | 365篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 29篇 |
儿科学 | 209篇 |
妇产科学 | 150篇 |
基础医学 | 662篇 |
口腔科学 | 44篇 |
临床医学 | 534篇 |
内科学 | 850篇 |
皮肤病学 | 72篇 |
神经病学 | 421篇 |
特种医学 | 99篇 |
外科学 | 340篇 |
综合类 | 19篇 |
一般理论 | 4篇 |
预防医学 | 539篇 |
眼科学 | 107篇 |
药学 | 371篇 |
中国医学 | 21篇 |
肿瘤学 | 380篇 |
出版年
2023年 | 43篇 |
2022年 | 22篇 |
2021年 | 104篇 |
2020年 | 76篇 |
2019年 | 133篇 |
2018年 | 148篇 |
2017年 | 118篇 |
2016年 | 115篇 |
2015年 | 122篇 |
2014年 | 189篇 |
2013年 | 225篇 |
2012年 | 363篇 |
2011年 | 361篇 |
2010年 | 214篇 |
2009年 | 187篇 |
2008年 | 320篇 |
2007年 | 297篇 |
2006年 | 300篇 |
2005年 | 287篇 |
2004年 | 316篇 |
2003年 | 257篇 |
2002年 | 219篇 |
2001年 | 38篇 |
2000年 | 16篇 |
1999年 | 26篇 |
1998年 | 55篇 |
1997年 | 34篇 |
1996年 | 17篇 |
1995年 | 22篇 |
1994年 | 32篇 |
1993年 | 30篇 |
1992年 | 10篇 |
1991年 | 7篇 |
1990年 | 5篇 |
1989年 | 9篇 |
1988年 | 11篇 |
1987年 | 5篇 |
1986年 | 6篇 |
1984年 | 11篇 |
1983年 | 8篇 |
1982年 | 10篇 |
1980年 | 6篇 |
1979年 | 4篇 |
1978年 | 4篇 |
1977年 | 6篇 |
1975年 | 4篇 |
1974年 | 6篇 |
1973年 | 5篇 |
1934年 | 3篇 |
1923年 | 4篇 |
排序方式: 共有4851条查询结果,搜索用时 31 毫秒
1.
2.
Background
The response to first-line, platinum-based treatment of muscle-invasive bladder cancer has not improved in 3 decades.Objective
To identify genes that influence cisplatin resistance in bladder cancer.Design, setting, and participants
We performed a whole-genome CRISPR screen in a bladder cancer cell line to identify genes that mediate resistance to cisplatin.Outcome measurements and statistical analysis
Targeted validation was performed in two bladder cancer cell lines. The top gene candidate was validated in a publicly available bladder cancer dataset.Results and limitations
From the CRISPR screen, we identified MSH2 as the most significantly enriched gene and mismatch repair as the most significantly enriched pathway that promoted resistance to cisplatin. Bladder cancer cells with knockdown of MSH2 showed a reduction in cisplatin-mediated apoptosis. MSH2 loss did not impact the sensitivity to other chemotherapies, including the cisplatin analog oxaliplatin. Bladder tumors with low MSH2 protein levels, quantified using reverse-phase protein array, showed poorer survival when treated with cisplatin- or carboplatin-based therapy; these results require future validation using immunohistochemistry. Additionally, results are retrospective from patients with primarily high-grade tumors; thus, validation in a controlled clinical trial is needed.Conclusions
We generated in vitro evidence that bladder cancer cell lines depleted of MSH2 are more resistant to cisplatin. We additionally found an association between low MSH2 in bladder tumors and poorer patient survival when treated with platinum-based chemotherapy. If successfully validated prospectively, MSH2 protein level could assist in the selection of patients for chemotherapy.Patient summary
We report the first evidence that MSH2 protein level may contribute to chemotherapy resistance observed in muscle-invasive bladder cancer. MSH2 has potential as a biomarker predictive of response to platinum-based therapy. 相似文献3.
Although working with trauma survivors can be a source of both deleterious and positive transformations in mental health professionals, little is known about the experience of clinicians in shared traumatic contexts, particularly in the Global South, where most humanitarian crises occur. In collective disasters or armed conflicts, the personal and professional experiences of mental health staff inform each other, situating the clinical space at the intersection between singular and collective spheres. Drawing on an intersubjective and socioecological perspective, this qualitative study explored the ways in which working in a shared traumatic context affected mental health and psychosocial staff in postearthquake Haiti. We interviewed 22 local mental health workers in the capital, Port‐au‐Prince, 2.5 years after the 2010 disaster. We coded and thematically analyzed interviews using an iterative process, based on grounded theory principles. Thematic analysis uncovered four dynamic poles in clinicians’ narratives: balancing duty and desire to help, experiencing fragility and strength, negotiating separation and connection, and sharing hurt and hope. Our findings suggest clinicians considered their work mainly as a source of strength in the face of adversity, whereas experiences of trauma and growth transmissions were mutual and intimately intertwined. We discuss the complexities of clinical work in shared traumatic settings as well as the dynamic interplay between professionals’ experiences of suffering and growth. We conclude with recommendations on ways to involve local mental health clinicians in postdisaster contexts while addressing the special needs that they may have to process their own trauma. 相似文献
4.
5.
6.
7.
8.
Usha Chakravarthy Natasha Pillai Annie Syntosi Lorna Barclay Catherine Best Alexandros Sagkriotis 《Eye (London, England)》2020,34(12):2249
Background/objectivesTo investigate the association between optical coherence tomography (OCT) markers of lesion activity and changes in visual acuity (VA) during anti-vascular endothelial growth factor (anti-VEGF) therapy of eyes diagnosed with neovascular age-related macular degeneration (nAMD); and how VA and OCT markers are considered in physicians’ decision to retreat with anti-VEGFs.Subjects/methodsRetrospective, non-comparative, non-randomised cohort study involving electronic medical record data collected from 1190 patient eyes with nAMD diagnosis at two sites in the United Kingdom. Two sub-cohorts consisting of 321 and 301 eyes, respectively, were selected for analyses.ResultsIn 321 eyes, absence of IRF or SRF at ≥2 clinic visits resulted in a gain of five ETDRS letters from baseline, compared with two letters gained in eyes with <2 clinic visits with absence of IRF (p = 0.006) or SRF (p = 0.042). Anti-VEGF treatment was administered at 421 clinic visits, and 308 visits were without treatment. Comparing treatment visits with non-treatment visits, the maximum difference in frequency of OCT markers of lesion activity were for intraretinal fluid (IRF; 24% versus 5%) and subretinal fluid (SRF; 32% versus 5%). Pigment epithelial detachment (PED) was reported in 58% of treatment visits compared with 36% in non-treatment visits. VA loss was not a consistent trigger for retreatment as it was present in 63% of injection visits and in 49% of non-injection visits.ConclusionsRetreatment decision making is most strongly influenced by the presence of IRF and SRF and less by the presence of PED or VA loss.Subject terms: Outcomes research, Macular degeneration 相似文献
9.
10.
Alan Y. Deng Julie-Émilie Huot-Marchard Denis deBlois Eric Thorin Cristina Chauvet Annie Menard 《The Canadian journal of cardiology》2019,35(5):661-670